DANIEL NAZON

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease ALBUQUERQUE, NM NPI 1386676476

General Payments — all program years on this page

$1,793.48

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 87
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $236.43 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $236.439

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Mylan Specialty L.P. $112.393
Boehringer Ingelheim Pharmaceuticals, Inc. $39.392
INOGEN, INC. $34.701
Acerta Pharma LLC $31.222
Grifols USA, LLC $18.731

By program year

Program yearAmountRecords
2018 $59.972
2019 $226.5314
2020 $89.585
2021 $44.973
2022 $516.7823
2023 $619.2231
2024 $236.439

Records — PY2024 (9)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104653545 AstraZeneca Pharmaceuticals LP $14.19 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105334221 AstraZeneca Pharmaceuticals LP $17.03 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117989762 Boehringer Ingelheim Pharmaceuticals, Inc. $15.12 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117989764 Boehringer Ingelheim Pharmaceuticals, Inc. $24.27 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124750775 Grifols USA, LLC $18.73 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144988827 INOGEN, INC. $34.70 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147292773 Mylan Specialty L.P. $41.47 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147298189 Mylan Specialty L.P. $36.08 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147370585 Mylan Specialty L.P. $34.84 12/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.